QIAGEN and Natera to Develop Cutting-Edge Pre-Natal Genetic Testing Assays
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
University of Sheffield scientists discover nine novel genes for osteoarthritis
To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017
CRISPR on-a-chip, digital PCR, and acoustic liquid handling steal the show at SLAS 2018
Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher
Register now to discover new, expert perspectives on process design, scale-up, and product safety
New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay
Josh Haimes, technical lead at ArcherDX, explains how successful NGS is influenced by step-by-step quality control
From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017
Dr. Michael Bianchi, senior lab manager at Empire Genomics explains the fundamental basis of a successful experiment – a protocol that works well.
Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases
Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease